▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3534 by analyst upside · 2026-08-12
AMN
AMN Healthcare Services, Inc.
Healthcare · Market Cap $1B · P/E 12.3x
ANALYST PRICE TARGET
+5.7%
implied upside to consensus target
Current Price $33.11
Consensus Target $35.0
Bull Target $40.0
Bear Target $26.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
2
Hold
4
Sell
0
52-Week Low $14.97
52-Week High $37.22
YTD Return +119.0%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 12.3x
Forward P/E 35.1x
EPS (TTM) $2.69
PEG Ratio 1.22
Dividend Yield N/A
Revenue (TTM) $3.4B
Profit Margin 3.1%
52-WEEK RANGE
52-Week Low $14.97
52-Week High $37.22
Current Price $33.11
Bear Target $26.0
Bull Target $40.0
● Now $33.11 ● Target $35.0
TRADING DATA
Avg Volume 979K
YTD Return +119.0%
Analyst Count 7
Consensus Buy
Upside to Target +5.7%
Last Updated 2026-08-12

ANALYST SUMMARY

AMN Healthcare Services, Inc. (AMN) is currently trading at $33.11 with a Wall Street consensus price target of $35.0, implying potential upside of 5.7% over the next 12 months. 7 analysts currently cover AMN, with a consensus rating of Buy - 43% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $40.0, while the most cautious has a target of $26.0.

AMN operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 119.0% year-to-date and is currently trading near the upper end of its 52-week range of $14.97 – $37.22.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

BVS +21.3%
Bioventus Inc.
$1B · P/E 17.8x · Buy
HCSG +27.9%
Healthcare Services Group, Inc.
$1B · P/E 12.3x · Hold
PAHC +32.0%
Phibro Animal Health Corporation
$1B · P/E 14.6x · Hold
CNMD -8.2%
CONMED Corporation
$1B · P/E 26.8x · Hold
INMD +1.3%
InMode Ltd.
$870M · P/E 12.5x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for AMN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS - Reiterated
Neutral → Neutral 2026-05-13 33% win rate (6 calls)
BMO Capital - Reiterated
Outperform → Outperform 2026-05-11 Building track record
Baird - Reiterated
Neutral → Neutral 2026-05-11 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-05-08 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-02-23 Building track record
Baird - Reiterated
Neutral → Neutral 2026-02-20 Building track record
UBS - Reiterated
Neutral → Neutral 2026-02-20 33% win rate (6 calls)
BMO Capital - Reiterated
Outperform → Outperform 2026-01-15 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
45
out of 100
Coverage depth
16/30
Consensus clarity
22/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →